BiotechTube
Home/Navigator Medicines/Dana McClintock, MD
DM

Dana McClintock, MD

Chief Medical Officer

Navigator Medicines

Therapeutic Areas

Inflammatory DisordersAutoimmune Diseases

Navigator Medicines Pipeline

DrugIndicationPhase
NAV-240Autoimmune Diseases (unspecified)Phase 2a
NAV-242Inflammatory/Autoimmune DiseasesPhase 1

Leadership Team at Navigator Medicines

T‘
Tausif ‘Tosh’ Butt
CEO and President
KG
Kristie Grebe, PhD
Chief Scientific Officer
SF
Scott Forrest, PhD
Chief Financial Officer
View full Navigator Medicines profile